Cargando…
Curcuminoids as Anticancer Drugs: Pleiotropic Effects, Potential for Metabolic Reprogramming and Prospects for the Future
The number of published studies on curcuminoids in cancer research, including its lead molecule curcumin and synthetic analogs, has been increasing substantially during the past two decades. Insights on the diversity of inhibitory effects they have produced on a multitude of pathways involved in car...
Autores principales: | Pouliquen, Daniel L., Trošelj, Koraljka Gall, Anto, Ruby John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303184/ https://www.ncbi.nlm.nih.gov/pubmed/37376060 http://dx.doi.org/10.3390/pharmaceutics15061612 |
Ejemplares similares
-
Editorial: Curcuminoids: their pleiotropism against hallmarks of cancers
por: Pouliquen, Daniel L., et al.
Publicado: (2023) -
Curcumin and its Potential for Systemic Targeting of Inflamm-Aging and Metabolic Reprogramming in Cancer
por: Kujundžić, Renata Novak, et al.
Publicado: (2019) -
EZH2 Inhibition and Cisplatin as a Combination Anticancer Therapy: An Overview of Preclinical Studies
por: Samaržija, Ivana, et al.
Publicado: (2022) -
Gene Expression Profiles – What the Clinician Needs to Know
por: Gall-Troselj, Koraljka
Publicado: (2005) -
Harris RJ, Korolchuk VI, eds. Biochemistry and Cell Biology of Aging: Part I Biomedical Science: Subcellular Biochemistry; Springer; e-book 531 pages, 2018; ISBN 978-981-13-2834-3; eISBN 978-981-13-2835-0
por: Gall Trošelj, Koraljka
Publicado: (2020)